Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Weidong ^a   Feng, Mei ^a   Fan, Zixuan ^a   Li, Jie ^a   Lang, Jinyi ^a  

^a SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; APLASIA; ARTICLE; BRAIN INJURY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CERVICAL LYMPH NODE; CHINA; CLINICAL EVALUATION; CLINICAL TARGET VOLUME; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; DYSPHAGIA; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; SKIN ATROPHY; SKIN FIBROSIS; SKIN MANIFESTATION; TREATMENT OUTCOME; TRISMUS; TUMOR VOLUME; XEROSTOMIA; CANCER STAGING; CONTROLLED STUDY; KAPLAN MEIER METHOD; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84924610095     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/814948     Document Type: Article

References (41)

1. J. C. Cheng, K. S. C. Chao, and D. Low, "Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma, " International Journal of Cancer, vol. 96, no. 2, pp. 126-131, 2001.
2. M. K. M. Kam, R. M. C. Chau, J. Suen, P. H. K. Choi, and P. M. L. Teo, "Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation, " International Journal of Radiation Oncology Biology Physics, vol. 56, no. 1, pp. 145-157, 2003.
3. P. Xia, K. K. Fu, G. W. Wong, C. Akazawa, and L. J. Verhey, "Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma, " International Journal of Radiation Oncology Biology Physics, vol. 48, no. 2, pp. 329-337, 2000.
4. M. K. M. Kam, P. M. L. Teo, R. M. C. Chau et al. , "Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience, " International Journal of Radiation Oncology Biology Physics, vol. 60, no. 5, pp. 1440-1450, 2004.
5. S. L. Wolden, W. C. Chen, D. G. Pfister, D. H. Kraus, S. L. Berry, and M. J. Zelefsky, "Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience, " International Journal of Radiation Oncology Biology Physics, vol. 64, no. 1, pp. 57-62, 2006.
6. N. Lee, P. Xia, J. M. Quivey et al. , "Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience, " International Journal of Radiation Oncology Biology? Physics, vol. 53, pp. 12-22, 2002.
7. D. L. W. Kwong, J. S. T. Sham, L. H. T. Leung et al. , "Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma, " International Journal of Radiation Oncology Biology Physics, vol. 64, no. 2, pp. 374-381, 2006.
8. D. L. W. Kwong, E. H. N. Pow, J. S. T. Sham et al. , "Intensitymodulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function, " Cancer, vol. 101, no. 7, pp. 1584-1593, 2004.
9. S. Lin, J. Pan, L. Han, X. Zhang, X. Liao, and J. J. Lu, "Nasopharyngeal carcinoma treated with reduced-volume intensitymodulated radiation therapy: report on the 3-year outcome of a prospective series, " International Journal of Radiation Oncology Biology Physics, vol. 75, no. 4, pp. 1071-1078, 2009.
10. N. Lee, J. Harris, A. S. Garden et al. , "Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225, " Journal of Clinical Oncology, vol. 27, no. 22, pp. 3684-3690, 2009.
11. I. W. Tham, S. W. Hee, R. M. Yeo et al. , "Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-The National Cancer Centre Singapore experience, " International Journal of Radiation Oncology, Biology, Physics, vol. 75, pp. 1481-1488, 2009.
12. W. T. Ng, M. C. H. Lee, W. M. Hung et al. , "Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma, " International Journal of Radiation Oncology Biology Physics, vol. 79, no. 2, pp. 420-428, 2011.
13. K. Sultanem, H. Shu, P. Xia et al. , "Three-dimensional intensitymodulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience, " International Journal of Radiation Oncology Biology Physics, vol. 48, no. 3, pp. 711-722, 2000.
14. C. Zhao, T. Lu, F. Han et al. , "Clinical results of 139 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy, " Chinese Journal of RadiationOncology, vol. 15, no. 1, pp. 1-6, 2006.
15. J. Chan, F. Bray, P. McCarron et al. , "Nasopharyngeal carcinoma, " in Pathology & Genetics of Head and Neck Tumours-World Health Organization Classification of Tumours, pp. 85-97, IARC Press, Lyon, France, 2005.
16. M. A. Hunt, M. J. Zelefsky, S. Wolden et al. , "Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer, " International Journal of Radiation Oncology Biology Physics, vol. 49, no. 3, pp. 623-632, 2001.
17. C. Chen, F. Han, C. Zhao et al. , "Long term effects of 934 nasopharyngeal carcinoma patients treated with 2D radiotherapy, " Chinese Journal of Radiation Oncology, vol. 17, no. 6, pp. 411-415, 2008.
18. J. S. K. Au, C. K. Law, W. Foo, and W. H. Lau, "In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinements, " International Journal of Radiation Oncology Biology Physics, vol. 56, no. 2, pp. 413-426, 2003.
19. P. M. Teo, P. Yu, W. Y. Lee et al. , "Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography, " International Journal of Radiation Oncology Biology Physics, vol. 36, no. 2, pp. 291-304, 1996.
20. A. W. M. Lee, Y. F. Poon, W. Foo et al. , "Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure, " International Journal of Radiation Oncology Biology Physics, vol. 23, no. 2, pp. 261-270, 1992.
21. P. Teo, S. Y. Tsao, W. Shiu et al. , "A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong, " InternationalJournal of Radiation Oncology Biology Physics, vol. 17, no. 3, pp. 515-530, 1989.
22. J. S. T. Sham and D. Choy, "Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-termsurvival, " Head and Neck, vol. 13, no. 4, pp. 298-310, 1991.
23. P. M. L. Teo, S. F. Leung, J. Fowler et al. , "Improved local control for early T-stage nasopharyngeal carcinoma-a tale of two hospitals, " Radiotherapy and Oncology, vol. 57, no. 2, pp. 155-166, 2000.
24. P. M. L. Teo, S. F. Leung, W. Y. Lee, and B. Zee, "Intracavitary brachytherapy significantly enhances local control of early Tstage nasopharyngeal carcinoma: the existence of a dose-tumorcontrol relationship above conventional tumoricidal dose, " International Journal of Radiation Oncology Biology Physics, vol. 46, no. 2, pp. 445-458, 2000.
25. C. Zhao, L. Lu, F. Han et al. , "Treatment outcomes of 122 nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy, " Chinese Journal of Radiation Oncology, vol. 15, no. 5, pp. 364-368, 2006.
26. S. Lin, C. Chen, L. Han et al. , "Preliminary results of 230 nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy, " Jounal of Fujian Medical University, vol. 41, no. 1, pp. 66-70, 2007.
27. C. Zhang, "Prospective study on the impact of radiotherapy on parotid function in nasopharyngeal carcinoma patients treatedwith intensity-modulatedradiotherapy, " Chinese Journal of Cancer, vol. 22, no. 4, pp. 380-383, 2007.
28. L. Nancy, P. Xia, N. J. Fischbein et al. , "Intensitymodulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation, " International Journal of Radiation Oncology Biology Physics, vol. 57, pp. 49-60, 2003.
29. A. Eisbruch, R. K. Ten Haken, H. M. Kim, L. H. Marsh, and J. A. Ship, "Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, " International Journal of Radiation Oncology Biology Physics, vol. 45, no. 3, pp. 577-587, 1999.
30. A. W. M. Lee, S. Y. Tung, A. T. C. Chan et al. , "Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma, " International Journal of RadiationOncology Biology Physics, vol. 66, no. 1, pp. 142-151, 2006.
31. A. W. M. Lee, W. H. Lau, S. Y. Tung et al. , "Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group, " Journal of Clinical Oncology, vol. 23, no. 28, pp. 6966-6975, 2005.
32. J. Wee, E. H. Tan, B. C. Tai et al. , "Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety, " Journal of Clinical Oncology, vol. 23, no. 27, pp. 6730-6738, 2005.
33. A. W. M. Lee, S. Y. Tung, R. K. C. Ngan et al. , "Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials, " European Journal of Cancer, vol. 47, no. 5, pp. 656-666, 2011.
34. A. W. M. Lee, S. Y. Tung, A. T. C. Chan et al. , "A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma, " Radiotherapy and Oncology, vol. 98, no. 1, pp. 15-22, 2011.
35. A. W. M. Lee, S. Y. Tung, D. T. T. Chua et al. , "Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma, " Journal of the National Cancer Institute, vol. 102, no. 15, pp. 1188-1198, 2010.
36. L. Han, S. Lin, J. Pan et al. , "Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy, " Chinese Journal of Cancer, vol. 29, no. 2, pp. 153-158, 2010.
37. M. Chen, T. H. Chen, J. Liu, C. Chang, and W. Chie, "Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume, " Cancer, vol. 100, no. 10, pp. 2160-2166, 2004.
38. C. C. Lee, T. T. Huang, M. S. Lee et al. , "Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome, " Radiation Oncology, vol. 5, article 20, 2010.
39. S. Wu and C. Zhao, "The impact of radiotherapy interruption and time delay on the clinical outcomes of nasopharyngeal carcinoma patients, " Chinese Journal Cancer, vol. 19, no. 10, pp. 923-926, 2000.
40. X. Huang, J. Hong, J. Pan et al. , "The effect of pretreatment hemoglobin levels on the long term outcomes of nasopharyngeal carcinoma patients treated with radiotherapy, " Journal of Fujian Medical University, vol. 40, no. 3, pp. 225-227, 2007.
41. J. Hu, "Effect of pretreatment bodymass index on the prognosis of nasopharyngeal carcinoma patients, " Chinese Journal of Cancer, vol. 28, no. 10, pp. 1043-1048, 2009.